BG1070U1 - Дозирана орална форма с продължително освобождаване на опиоиди за намаляване на предизвикан от алкохол дъмпинг на дозата - Google Patents
Дозирана орална форма с продължително освобождаване на опиоиди за намаляване на предизвикан от алкохол дъмпинг на дозата Download PDFInfo
- Publication number
- BG1070U1 BG1070U1 BG1150U BG115006U BG1070U1 BG 1070 U1 BG1070 U1 BG 1070U1 BG 1150 U BG1150 U BG 1150U BG 115006 U BG115006 U BG 115006U BG 1070 U1 BG1070 U1 BG 1070U1
- Authority
- BG
- Bulgaria
- Prior art keywords
- dosage form
- oral dosage
- release
- drug
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73199505P | 2005-10-31 | 2005-10-31 | |
US80201706P | 2006-05-18 | 2006-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
BG1070U1 true BG1070U1 (bg) | 2008-06-30 |
Family
ID=36758362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG1150U BG1070U1 (bg) | 2005-10-31 | 2006-12-21 | Дозирана орална форма с продължително освобождаване на опиоиди за намаляване на предизвикан от алкохол дъмпинг на дозата |
Country Status (11)
Country | Link |
---|---|
BG (1) | BG1070U1 (sv) |
CA (6) | CA2554874A1 (sv) |
CZ (1) | CZ19137U1 (sv) |
DK (1) | DK200600189U3 (sv) |
FI (1) | FI7357U1 (sv) |
GB (1) | GB0612326D0 (sv) |
IE (1) | IES20060507A2 (sv) |
NL (1) | NL1032148C1 (sv) |
NO (1) | NO20063233L (sv) |
SE (1) | SE0601589L (sv) |
SK (1) | SK5202Y1 (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2187873T3 (pl) | 2007-08-13 | 2019-01-31 | Abuse Deterrent Pharmaceutical Llc | Leki odporne na nadużywanie, metoda stosowania i metoda wytwarzania |
US11571390B2 (en) | 2013-03-15 | 2023-02-07 | Othemo Life Sciences, Inc. | Abuse deterrent compositions and methods of use |
US10729685B2 (en) | 2014-09-15 | 2020-08-04 | Ohemo Life Sciences Inc. | Orally administrable compositions and methods of deterring abuse by intranasal administration |
US10172842B2 (en) * | 2015-09-11 | 2019-01-08 | PharmaDax Inc. | Sustained release oral dosage form containing dalfampridine |
-
2006
- 2006-06-21 GB GBGB0612326.9A patent/GB0612326D0/en not_active Ceased
- 2006-07-11 IE IE20060507A patent/IES20060507A2/en not_active IP Right Cessation
- 2006-07-11 NO NO20063233A patent/NO20063233L/no not_active Application Discontinuation
- 2006-07-11 NL NL1032148A patent/NL1032148C1/nl not_active IP Right Cessation
- 2006-07-12 DK DK200600189U patent/DK200600189U3/da not_active IP Right Cessation
- 2006-07-12 FI FI20060296U patent/FI7357U1/sv not_active IP Right Cessation
- 2006-07-12 CZ CZ200617928U patent/CZ19137U1/cs not_active IP Right Cessation
- 2006-07-13 SK SK5057-2006U patent/SK5202Y1/sk unknown
- 2006-07-20 SE SE0601589A patent/SE0601589L/sv not_active Application Discontinuation
- 2006-07-31 CA CA002554874A patent/CA2554874A1/en not_active Abandoned
- 2006-07-31 CA CA002554701A patent/CA2554701A1/en not_active Abandoned
- 2006-07-31 CA CA002554693A patent/CA2554693A1/en not_active Abandoned
- 2006-07-31 CA CA002554697A patent/CA2554697A1/en not_active Abandoned
- 2006-07-31 CA CA002554684A patent/CA2554684A1/en not_active Abandoned
- 2006-07-31 CA CA002554698A patent/CA2554698A1/en not_active Abandoned
- 2006-12-21 BG BG1150U patent/BG1070U1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
SK50572006U1 (en) | 2009-01-07 |
CA2554698A1 (en) | 2007-04-30 |
IES20060507A2 (en) | 2007-05-30 |
DK200600189U3 (da) | 2007-02-23 |
FIU20060296U0 (sv) | 2006-07-12 |
CA2554874A1 (en) | 2007-04-30 |
CA2554701A1 (en) | 2007-04-30 |
CA2554697A1 (en) | 2007-04-30 |
CZ19137U1 (cs) | 2008-12-08 |
GB0612326D0 (en) | 2006-08-02 |
SK5202Y1 (en) | 2009-06-05 |
SE0601589L (sv) | 2007-05-01 |
NO20063233L (no) | 2007-05-02 |
NL1032148C1 (nl) | 2006-11-17 |
CA2554684A1 (en) | 2007-04-30 |
FI7357U1 (sv) | 2007-01-16 |
CA2554693A1 (en) | 2007-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG1145U1 (bg) | Дозирана орална форма с продължително освобождаване на опиоиди за намаляване на предизвикан от алкохол дъмпинг на дозата | |
KR101169614B1 (ko) | 상승한 방출 속도를 나타내는 제어 방출 제제 | |
JP2003509354A (ja) | 1日1回投与で有効なレボキセチン治療を与える製剤及び方法 | |
BG1070U1 (bg) | Дозирана орална форма с продължително освобождаване на опиоиди за намаляване на предизвикан от алкохол дъмпинг на дозата | |
EP1849460A2 (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | |
CN1957909B (zh) | 降低***样物质持续释放口服剂型的由醇诱导的剂量突然释放的方法 | |
ITTO20060161U1 (it) | Procedimenti per ridurre il rilascio precipitoso indotto da alcool per forme di dosaggio orali a rilascio prolungato di oppioidi | |
ITTO20060112U1 (it) | Procedimenti per ridurre il rilascio precipitoso indotto da alcool per forme di dosaggio orali a rilascio prolungato di oppioidi. | |
IES84730Y1 (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms |